Published January 25, 2005
| Version v1
Patent
Open
Genetically engineered herpes virus for the treatment of cardiovascular disease
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The present invention provides methods of expressing a nucleic acid or producing a proteinaceous composition encoded by a nucleic acid in vascular and cardiovascular cells by administration of a herpesvirus vector. The present invention provides methods of producing a therapeutic benefit in vascular and cardiovascular tissue by administration of a herpesvirus vector. In additional aspects, the invention concerns combination therapies for vascular and cardiovascular diseases comprising administration of a herpesvirus vector and treatment with at least one addition pharmacological agent or surgical procedure.
Files
US6846670.pdf
Files
(2.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:4ce8c31ea2aa2b6be480a2f7b81e36f8
|
2.6 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 99547501 A
- Patent number
- US 6846670 B2
- Other
- oai:uchicago.tind.io:9236
Dates
- Patent filed
-
2001-11-28